Stealth BioTherapeutics Corp (MITO)
Q4 2019 Earnings Conference Call
April 01, 2020 08:30 AM ET
Company Participants
Henry Hess - Chief Legal Counsel
Reenie McCarthy - Chief Executive Officer
Rob Weiskopf - Chief Financial Officer
Jim Carr - Chief Clinical Development Officer
Brian Blakey - Chief Commercial Officer
Conference Call Participants
Charles Duncan - Cantor Fitzgerald
Christopher Marai - Nomura Instinet
Matthew Luchini - BMO
Yi Chen - H.C. Wainwright
Maury Raycroft - Jefferies
Presentation
Operator
Greetings, and welcome to the Stealth BioTherapeutics Fiscal Year 2019 Financial Results and recent business highlights call. At this